Evaluating the Effect of Digoxin and Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis
Status:
Not yet recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the potential therapeutic effects of the cardiac
glycoside digoxin and the secondary bile acid ursodeoxycholic acid (UDCA) on synovial
inflammation and disease activity when administered as add-on treatments to the current
DMARDs treatments for rheumatoid arthritis patients with variant disease activity.